Literature DB >> 31005866

Complex encephalopathy arising from the combination of opioids and gabapentin.

Harpreet Singh1,2, Richa Handa3, Vivek Kak1, Alicja Wasilewski3.   

Abstract

The interactions between opioids and gabapentin are more clinically relevant than ever. Prescriptions dispensed for gabapentin increased from 39 million in 2012 to 64 million in 2018 in the USA and are ever increasing. Authors present a challenging case of these interactions. A 58-year-old man presented to the emergency department with acute respiratory failure and altered mental status. He was on high dose opioids and gabapentin as prescription medications. Despite full intensive care support and resolution of his respiratory failure with non-invasive positive pressure ventilation, the patient did not regained consciousness. After ruling out other causes, the diagnosis of gabapentin withdrawal was considered. Gabapentin was administered by a nasogastric tube that quickly resulted in a reversal of his symptoms. We concluded that severe gabapentin withdrawal should be considered in patients on higher doses of gabapentin when it is stopped abruptly. In such patients, gabapentin should be replaced. As most patients are unable to swallow in this situation and intravenous formulation is not available, nasogastric tube can be used for replacement. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  adult intensive care; drug interactions; drugs and medicines; drugs: cns (not psychiatric)

Mesh:

Substances:

Year:  2019        PMID: 31005866      PMCID: PMC6506108          DOI: 10.1136/bcr-2018-228354

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  20 in total

1.  Abuse, dependency and withdrawal with gabapentin: a first case report.

Authors:  C Victorri-Vigneau; M Guerlais; P Jolliet
Journal:  Pharmacopsychiatry       Date:  2007-01       Impact factor: 5.788

2.  Gabapentin in the treatment of antipsychotic-induced akathisia in schizophrenia.

Authors:  Gerald Pfeffer; Guy Chouinard; Howard C Margolese
Journal:  Int Clin Psychopharmacol       Date:  2005-05       Impact factor: 1.659

3.  Misuse of gabapentin and pregabalin: a marker for a more serious malaise?

Authors:  Cathy Stannard
Journal:  Addiction       Date:  2016-07-25       Impact factor: 6.526

4.  Patterns of naloxone use in hospitalized patients.

Authors:  Lisa Yung; Kelly C Lee; Chih Hsu; Timothy Furnish; Rabia S Atayee
Journal:  Postgrad Med       Date:  2016-12-01       Impact factor: 3.840

Review 5.  Gabapentin: Abuse, Dependence, and Withdrawal.

Authors:  Tracey L Mersfelder; William H Nichols
Journal:  Ann Pharmacother       Date:  2015-12-31       Impact factor: 3.154

6.  Akathisia induced by gabapentin withdrawal.

Authors:  Sharon See; Erin Hendriks; Leslie Hsiung
Journal:  Ann Pharmacother       Date:  2011-06-07       Impact factor: 3.154

7.  Gabapentin enhances the analgesic effect of morphine in healthy volunteers.

Authors:  K Eckhardt; S Ammon; U Hofmann; A Riebe; N Gugeler; G Mikus
Journal:  Anesth Analg       Date:  2000-07       Impact factor: 5.108

8.  Co-administration of morphine and gabapentin leads to dose dependent synergistic effects in a rat model of postoperative pain.

Authors:  Theodoros Papathanasiou; Rasmus Vestergaard Juul; Anne-Marie Heegaard; Mads Kreilgaard; Trine Meldgaard Lund
Journal:  Eur J Pharm Sci       Date:  2015-11-21       Impact factor: 4.384

Review 9.  Gabapentin misuse, abuse and diversion: a systematic review.

Authors:  Rachel V Smith; Jennifer R Havens; Sharon L Walsh
Journal:  Addiction       Date:  2016-03-18       Impact factor: 6.526

10.  Abuse of Gabapentin is Associated with Opioid Addiction.

Authors:  Leo Bastiaens; James Galus; Cherise Mazur
Journal:  Psychiatr Q       Date:  2016-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.